The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults by Khan O, Chaudary N

Get full text

High-risk melanoma with nodal involvement in a young woman. by Khan, O, Middleton, M

The therapeutic potential of O6-alkylguanine DNA alkyltransferase inhibitors. by Khan, O, Middleton, MR

Outcomes of Combined iStent Trabecular Micro-Bypass and Cataract Surgery for the Treatment of Open-Angle Glaucoma in a Saudi Population by Al Habash A, Khan O

Get full text

HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications. by Khan, O, La Thangue, N

Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas. by Khan, O, La Thangue, N

Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppression by Khan O. Mohammad, Hanna Fanous, Sneha Vakamudi, Yan Liu

Get full text

Kaolin-induced hydrocephalus in the newborn rat by Enno T, Khan O, Del Bigio M, McPhee L

CARDIAC REHABILITATION: TRENDS IN MEDICARE UTILIZATION AND REIMBURSEMENT by Khan O. Mohammad, Charles Hyman, George Rodgers, Clay Cauthen

Get full text

HDAC inhibitor-based therapies and haematological malignancy. by Stimson, L, Wood, V, Khan, O, Fotheringham, S, La Thangue, N

Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer. by Khan, O, Fitzgerald, J, Soomro, I, Beggs, F, Morgan, W, Duffy, J

Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung. by Khan, O, Fitzgerald, J, Field, M, Soomro, I, Beggs, F, Morgan, W, Duffy, J

Genome-wide loss-of-function screen reveals an important role for the proteasome in HDAC inhibitor-induced apoptosis. by Fotheringham, S, Epping, M, Stimson, L, Khan, O, Wood, V, Pezzella, F, Bernards, R, La Thangue, N

HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy. by Khan, O, Fotheringham, S, Wood, V, Stimson, L, Zhang, C, Pezzella, F, Duvic, M, Kerr, D, La Thangue, N

Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer by Khan, O, Blann, A, Payne, M, Middleton, MR, Protheroe, A, Talbot, D, Taylor, M, Han, C, Patil, M, Harris, A

Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate by Khan, O, Blann, A, Payne, M, Middleton, MR, Protheroe, A, Talbot, D, Taylor, M, Han, C, Patil, M, Harris, A

A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer. by Khan, O, Ranson, M, Michael, M, Olver, I, Levitt, N, Mortimer, P, Watson, A, Margison, G, Midgley, R, Middleton, MR

Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate. by Khan, O, Blann, A, Payne, M, Middleton, MR, Protheroe, A, Talbot, D, Taylor, M, Han, C, Patil, M, Harris, A

Prognosis in Hispanic patient population with pulmonary arterial hypertension: An application of common risk stratification models by Kahtan Fadah, Jose B. Cruz Rodriguez, Haider Alkhateeb, Debabrata Mukherjee, Hernando Garcia, Dan Schuller, Khan O. Mohammad, Sandeep Sahay, Nils P. Nickel

Get full text

Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer. by Khan, O, Blann, A, Payne, M, Middleton, MR, Protheroe, A, Talbot, D, Taylor, M, Kirichek, O, Han, C, Patil, M, Harris, A